Related Experiment Videos
[Calcium antagonist enhancement of cardiac resistance to immune damage]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|July 1, 1994
Abstract:
Finoptin in a dose of 0,145 mg/kg prevented cardiomyocytic immune disorders in dogs and rats with cardiogenic shock of immune genesis. In test systems, the drug and nifedipine reduced the immune lysis in the cells by the complement.